{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:16:49Z","timestamp":1777349809559,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1124\/dmd.116.074344","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T01:55:33Z","timestamp":1488506133000},"page":"512-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Effects of MicroRNA-34a on the Pharmacokinetics of Cytochrome P450 Probe Drugs in Mice"],"prefix":"10.1016","volume":"45","author":[{"given":"Joseph L.","family":"Jilek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Ming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.116.074344_bib1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1124\/dmd.116.074344_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0253-7613.81512","article-title":"A comparative study of the pharmacokinetics of traditional and automated dosing\/blood sampling systems using gabapentin","volume":"43","author":"Aryal","year":"2011","journal-title":"Indian J Pharmacol"},{"key":"10.1124\/dmd.116.074344_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34 - a microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Front Genet"},{"key":"10.1124\/dmd.116.074344_bib4","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1158\/0008-5472.CAN-10-2010","article-title":"The promise of microRNA replacement therapy","volume":"70","author":"Bader","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.116.074344_bib5","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/db08-0812","article-title":"Functional targets of the monogenic diabetes transcription factors HNF-1alpha and HNF-4alpha are highly conserved between mice and humans","volume":"58","author":"Boj","year":"2009","journal-title":"Diabetes"},{"key":"10.1124\/dmd.116.074344_bib6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1124\/dmd.108.024190","volume":"37","author":"Buckley","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074344_bib7","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1124\/mol.105.013680","article-title":"Retinoid X receptor alpha regulates the expression of glutathione S-transferase genes and modulates acetaminophen-glutathione conjugation in mouse liver","volume":"68","author":"Dai","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.116.074344_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/21655979.2016.1207011","article-title":"Bioengineered non-coding RNA agent (BERA) in action","volume":"7","author":"Duan","year":"2016","journal-title":"Bioengineered"},{"key":"10.1124\/dmd.116.074344_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1124\/dmd.31.5.548","article-title":"Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam","volume":"31","author":"Granvil","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074344_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/wrna.1324","article-title":"Bioengineering of noncoding RNAs for research agents and therapeutics","volume":"7","author":"Ho","year":"2016","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1124\/dmd.116.074344_bib11","doi-asserted-by":"crossref","first-page":"e113305","DOI":"10.1371\/journal.pone.0113305","article-title":"The role of miR-34a in the hepatoprotective effect of hydrogen sulfide on ischemia\/reperfusion injury in young and old rats","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/dmd.116.074344_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.vascn.2007.05.006","article-title":"Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs","volume":"56","author":"Hui","year":"2007","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/dmd.116.074344_bib13","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1124\/dmd.113.053157","article-title":"Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport","volume":"41","author":"Ingelman-Sundberg","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074344_bib14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/dmd.112.050724","article-title":"Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 status","volume":"41","author":"Jiang","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074344_bib15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/dmd.116.074344_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-3565(25)33564-0","article-title":"In vivo O-de-ethylation of phenacetin in 3-methylcholanthrene-pretreated rats: gut wall and liver first-pass metabolism","volume":"225","author":"Klippert","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.074344_bib17","doi-asserted-by":"crossref","unstructured":"Knights KM, Stresser DM, Miners JO, Crespi CL (2016) In vitro drug metabolism using liver microsomes. Curr Protoc Pharmacol 74:7.8.1\u20137.8.24.","DOI":"10.1002\/cpph.9"},{"key":"10.1124\/dmd.116.074344_bib18","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1124\/jpet.102.035972","article-title":"In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat","volume":"302","author":"Kotegawa","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.074344_bib19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1177\/0091270003259216","article-title":"Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone","volume":"43","author":"Lam","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.116.074344_bib20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbrc.2014.02.024","article-title":"microRNA-34a is associated with expression of key hepatic transcription factors and cytochromes P450","volume":"445","author":"Lamba","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.116.074344_bib21","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1177\/00912709922012015","article-title":"Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity","volume":"39","author":"McCrea","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.116.074344_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bcp.2014.05.002","article-title":"Retinoid X receptor \u03b1 in human liver is regulated by miR-34a","volume":"90","author":"Oda","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.074344_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/00498254.2010.527021","article-title":"Pregnane X receptor-mediated induction of Cyp3a by black cohosh","volume":"41","author":"Pang","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.074344_bib24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/tx00034a019","article-title":"Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics","volume":"6","author":"Patten","year":"1993","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.116.074344_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-3565(24)35332-7","article-title":"Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms","volume":"292","author":"Perloff","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.074344_bib26","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1124\/mol.112.080036","article-title":"Generation and characterization of novel cytochrome P450 Cyp2c gene cluster knockout and CYP2C9 humanized mouse lines","volume":"82","author":"Scheer","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.116.074344_bib27","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1124\/dmd.111.039107","article-title":"Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice","volume":"39","author":"Shen","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074344_bib28","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1074\/jbc.M109.085431","article-title":"MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle","volume":"285","author":"Takagi","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.116.074344_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0090-9556(24)14912-4","article-title":"Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites","volume":"27","author":"Tang","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074344_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/0023677214541438","article-title":"Manual versus automated blood sampling: impact of repeated blood sampling on stress parameters and behavior in male NMRI mice","volume":"48","author":"Teilmann","year":"2014","journal-title":"Lab Anim"},{"key":"10.1124\/dmd.116.074344_bib31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0009-9236(99)70009-3","article-title":"Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole","volume":"66","author":"Tsunoda","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.116.074344_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/jpet.115.225631","article-title":"Bioengineering novel chimeric microRNA-34a for prodrug cancer therapy: high-yield expression and purification, and structural and functional characterization","volume":"354","author":"Wang","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.074344_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev-pharmtox-011112-140250","article-title":"microRNAs as mediators of drug toxicity","volume":"53","author":"Yokoi","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.116.074344_bib34","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1517\/17425250903307448","article-title":"Role of microRNAs in the regulation of drug metabolism and disposition","volume":"5","author":"Yu","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.116.074344_bib35","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1124\/dmd.105.008870","article-title":"Expression, purification, and characterization of mouse CYP2d22","volume":"34","author":"Yu","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074344_bib36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/dmd.115.067470","article-title":"MicroRNA pharmacoepigenetics: posttranscriptional regulation mechanisms behind variable drug disposition and strategy to develop more effective therapy","volume":"44","author":"Yu","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074344_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/taap.1998.8501","article-title":"Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice","volume":"152","author":"Zaher","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.116.074344_bib38","doi-asserted-by":"crossref","first-page":"26611","DOI":"10.1038\/srep26611","article-title":"Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.116.074344_bib39","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bcp.2015.10.015","article-title":"Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth","volume":"98","author":"Zhao","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.074344_bib40","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1124\/dmd.113.053199","article-title":"Identification and characterization of psoralen and isopsoralen as potent CYP1A2 reversible and time-dependent inhibitors in human and rat preclinical studies","volume":"41","author":"Zhuang","year":"2013","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.116.074344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:21:52Z","timestamp":1739902912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624053418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0090955624053418"],"URL":"https:\/\/doi.org\/10.1124\/dmd.116.074344","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of MicroRNA-34a on the Pharmacokinetics of Cytochrome P450 Probe Drugs in Mice","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.116.074344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}